Advanced search
Publication Cover
Leukemia & Lymphoma Volume 52, 2011 - Issue 2
Submit an article Journal homepage
156
Views
4
CrossRef citations to date
0
Altmetric
Letters to the Editor

Concomitant FIP1L1–PDGFRA fusion gene and T-cell clonality in a case of chronic eosinophilic leukemia with clonal evolution and an incomplete response to imatinib

Kate BurburyDepartment of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, AustraliaCorrespondence[email protected]
,
Lee Ping ChewDepartment of Haematology, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
,
David Westerman
,
Alberto CatalanoMolecular Haematology Laboratory, Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
&
John F. Seymour
Pages 335-338 | Received 27 Jul 2010, Accepted 18 Oct 2010, Published online: 01 Feb 2011
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.